Search results for "Random"

showing 10 items of 3931 documents

Mediterranean diet and health: A systematic review of epidemiological studies and intervention trials

2019

Diet is a crucial variable for a healthy life. A rapidly growing number of studies in recent years support the hypothesis that the Mediterranean diet (MedDiet) has a beneficial effect on certain body systems, but the highly varied objectives and quality of these publications warrants an updated assessment. In the present review we performed a comprehensive evaluation of current evidence on the impact of the MedDiet on human health, assessing its effect on the incidence or progression of the main non-communicable diseases and their intermediate outcomes and risk factors. We scrutinised the clinical evidence from observational studies and randomised controlled trials. Cardiovascular disease w…

medicine.medical_specialtyMediterranean dietDiseaseDiet MediterraneanGeneral Biochemistry Genetics and Molecular BiologyCognitionNeoplasmsEnvironmental healthEpidemiologyDiabetes MellitusmedicineHumansRandomized Controlled Trials as Topicbusiness.industryIncidence (epidemiology)Obstetrics and Gynecologymedicine.diseaseObesityEpidemiologic StudiesObservational Studies as TopicMoodCardiovascular DiseasesOsteoporosisObservational studyMenopauseMetabolic syndromebusinessMaturitas
researchProduct

Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case–control, cohort and intervention studies

2014

Increasing evidence suggests that the Mediterranean diet can reduce the risk of CVD. Olive oil is the hallmark of this dietary pattern. We conducted a meta-analysis of case–control, prospective cohort studies and a randomised controlled trial investigating the specific association between olive oil consumption and the risk of CHD (101 460 participants) or stroke (38 673 participants). The results of all observational studies were adjusted for total energy intake. The random-effects model assessing CHD as an outcome showed a relative risk (RR) of 0·73 (95 % CI 0·44, 1·21) in case–control studies and 0·96 (95 % CI 0·78, 1·18) in cohort studies for a 25 g increase in olive oil consumption. In …

medicine.medical_specialtyMediterranean dietMedicine (miscellaneous)Coronary DiseaseDiet MediterraneanCohort StudiesRisk FactorsOleaInternal medicinemedicineHumansPlant Oilscardiovascular diseasesProspective cohort studyOlive OilStrokeRandomized Controlled Trials as TopicEvidence-Based MedicineNutrition and Dieteticsbusiness.industryIncidenceCase-control studyReproducibility of Resultsmedicine.diseaseStrokeCase-Control StudiesFruitRelative riskMeta-analysisCohortPhysical therapybusinessCohort studyBritish Journal of Nutrition
researchProduct

Mediterranean diet and antihypertensive drug use: a randomized controlled trial

2021

Objective To examine in older individuals at high cardiovascular risk whether following a Mediterranean diet decreased the necessity of antihypertensive drugs and modulated their associated cardiovascular risk. Methods In the PREvencion con DIeta MEDiterranea study, we assessed whether volunteers randomly allocated to an intervention with a Mediterranean diet enriched with extra-virgin olive oil or nuts (relative to a low-fat control diet) disclosed differences in the risk of: initiating antihypertensive medication in nonusers at baseline (n = 2188); and escalating therapy in participants using one, two, or three drugs at baseline (n = 2361, n = 1579, and n = 554, respectively). We also ass…

medicine.medical_specialtyMediterranean dietPhysiologymedicine.drug_classPsychological intervention030204 cardiovascular system & hematologyDiet MediterraneanLower risklaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawInternal medicineInternal MedicinemedicineHumansNuts030212 general & internal medicineAntihypertensive drugOlive OilAntihypertensive AgentsAgedbusiness.industryIncidence (epidemiology)Hazard ratioCardiovascular DiseasesCardiology and Cardiovascular MedicinebusinessOlive oilJournal of Hypertension
researchProduct

Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial

2015

Importance Breast cancer is the leading cause of female cancer burden, and its incidence has increased by more than 20% worldwide since 2008. Some observational studies have suggested that the Mediterranean diet may reduce the risk of breast cancer. Objective To evaluate the effect of 2 interventions with Mediterranean diet vs the advice to follow a low-fat diet (control) on breast cancer incidence. Design, Setting, and Participants The PREDIMED study is a 1:1:1 randomized, single-blind, controlled field trial conducted at primary health care centers in Spain. From 2003 to 2009, 4282 women aged 60 to 80 years and at high cardiovascular disease risk were recruited after invitation by their p…

medicine.medical_specialtyMediterranean dietSistema cardiovascular -- MalaltiesDonesCàncer de mamalaw.inventionMedicina preventivaClinical trialsMediterranean cookingBreast cancerBreast cancerDiet and cancerBreast Cancer Prevention TrialRandomized controlled triallawInternal medicineCuina mediterràniaInternal MedicinemedicineWomenDieta -- Mediterrània Regió de laPreventive medicinebusiness.industryIncidence (epidemiology)Hazard ratiomedicine.diseaseSurgeryMama -- CàncerObservational studybusinessAssaigs clínicsJAMA Internal Medicine
researchProduct

The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial.

2013

Summary Background & aims Metabolic syndrome (MetS), in which a non-classic feature is an increase in systemic oxidative biomarkers, presents a high risk of diabetes and cardiovascular disease (CVD). Adherence to the Mediterranean Diet (MedDiet) is associated with a reduced risk of MetS. However, the effect of the MedDiet on biomarkers for oxidative damage has not been assessed in MetS individuals. We have investigated the effect of the MedDiet on systemic oxidative biomarkers in MetS individuals. Methods Randomized, controlled, parallel clinical trial in which 110 female with MetS, aged 55–80, were recruited into a large trial (PREDIMED Study) to test the efficacy of the traditional MedDie…

medicine.medical_specialtyMediterranean dietUrinary systemCritical Care and Intensive Care Medicinemedicine.disease_causeDiet Mediterraneanlaw.inventionRandomized controlled triallawRisk FactorsInternal medicineDiabetes mellitusmedicineHumansNutsPlant OilsDiet Fat-RestrictedOlive OilAgedAged 80 and overMetabolic SyndromeF2-IsoprostanesNutrition and Dieteticsbusiness.industryDeoxyguanosineMiddle Agedmedicine.diseaseLipid MetabolismClinical trialOxidative StressEndocrinology8-Hydroxy-2'-DeoxyguanosineCardiovascular DiseasesFemaleMetabolic syndromebusinessBody mass indexRisk Reduction BehaviorOxidative stressBiomarkersDNA DamageClinical nutrition (Edinburgh, Scotland)
researchProduct

The Mediterranean diet, plasma metabolome, and cardiovascular disease risk.

2020

Abstract Aims To investigate whether metabolic signature composed of multiple plasma metabolites can be used to characterize adherence and metabolic response to the Mediterranean diet and whether such a metabolic signature is associated with cardiovascular disease (CVD) risk. Methods and results Our primary study cohort included 1859 participants from the Spanish PREDIMED trial, and validation cohorts included 6868 participants from the US Nurses’ Health Studies I and II, and Health Professionals Follow-up Study (NHS/HPFS). Adherence to the Mediterranean diet was assessed using a validated Mediterranean Diet Adherence Screener (MEDAS), and plasma metabolome was profiled by liquid chromatogr…

medicine.medical_specialtyMediterranean dietbusiness.industryIncidence (epidemiology)Hazard ratioDiseaseOdds ratio030204 cardiovascular system & hematologyDiet Mediterranean03 medical and health sciences0302 clinical medicineCardiovascular DiseasesRisk FactorsInternal medicineCohortMendelian randomizationMetabolomemedicineMetabolomeHumans030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesGenome-Wide Association StudyEuropean heart journal
researchProduct

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-contro…

2009

Background Mastocytosis is characterized by the accumulation and activation of mast cells in different organs, most commonly the skin. Miltefosine, a raft modulator, has recently been shown to inhibit the activation of mast cells and to reduce mast cell-driven skin inflammatory responses. Objectives To study the safety and efficacy of topical miltefosine treatment of skin lesions in patients with mastocytosis. Methods Thirty-nine adult patients with mastocytosis with skin involvement were treated in a double-blind, placebo-controlled, parallel trial with topical miltefosine and clobetasol for 2 weeks. Treatment areas were analysed for changes in skin lesions and symptoms following mechanica…

medicine.medical_specialtyMiltefosinebusiness.industryCutaneous MastocytosisProvocation testPlacebo-controlled studyDermatologyMast cellDermatologylaw.inventionmedicine.anatomical_structurePharmacotherapyRandomized controlled trialDermislawMedicinebusinessmedicine.drugBritish Journal of Dermatology
researchProduct

Tai Chi for Chronic Illness Management: Synthesizing Current Evidence from Meta-Analyses of Randomized Controlled Trials

2021

An umbrella review of systematic reviews and meta-analyses of randomized controlled trials (RCTs) was conducted to evaluate the existing evidence of Tai Chi as a mind-body exercise for chronic illness management. MEDLINE/PubMed and Embase databases were searched from inception until March 31, 2019, for meta-analyses of at least two RCTs that investigated health outcomes associated with Tai Chi intervention. Evidence of significant outcomes (P value < 0.05) was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. This review identified 45 meta-analyses of RCTs and calculated 142 summary estimates among adults living with 16 types of chronic …

medicine.medical_specialtyMind-body exerciseMEDLINE030204 cardiovascular system & hematologyHealth outcomesTai Chilaw.inventionUmbrella review03 medical and health sciences0302 clinical medicineRandomized controlled trialMeta-Analysis as TopiclawChronic illness managementmedicineChronic illneHumans030212 general & internal medicineRandomized Controlled Trials as Topicbusiness.industryMind-Body TherapiesGeneral MedicinePeer reviewMind/body exerciseSystematic reviewRandomized controlled trialChronic DiseasePhysical therapyQuality of LifeTai Jibusiness
researchProduct

Interventions for reducing loneliness: An umbrella review of intervention studies

2020

Loneliness is a common phenomenon associated with several negative health outcomes. Current knowledge regarding interventions for reducing loneliness in randomised controlled trials (RCTs) is conflicting. The aim of the present work is to provide an overview of interventions to reduce loneliness, using an umbrella review of previously published systematic reviews and meta-analyses. We searched major databases from database inception to 31 March 2020 for RCTs comparing active versus non-active interventions for reducing loneliness. For each intervention, random-effects summary effect size and 95% confidence intervals (CIs) were calculated. For significant outcomes (p-value < 0.05), the GR…

medicine.medical_specialtyMindfulnessSociology and Political Sciencebusiness.industryLonelinessHealth PolicyClinical Studies as TopicPublic Health Environmental and Occupational HealthPsychological interventionLonelinesslaw.inventionSocial supportSystematic reviewRandomized controlled triallawMeta-analysisloneliness meta-analysis randomised controlled trial social umbrella reviewmedicinePhysical therapyHumansmedicine.symptombusinessMindfulnessSocial Sciences (miscellaneous)Social cognitive theoryHealth & Social Care in the Community
researchProduct

New approaches in the treatment of Adamantiades-Behçet's disease.

2005

Purpose of review To update clinicians on the recent advances in the treatment of Adamantiades-Behcet's disease. Recent findings Interferon-α-2a and infliximab have proved able to induce prompt remission in the vast majority of Adamantiades-Behcet's patients with DMARD-resistant uveoretinitis. Efficacy of interferon-α-2a has also been reported for mucocutaneous lesions, arthritis, and (more anecdotally) for neuro-Behcet, while results from small case series suggest that infliximab is beneficial for mucocutaneous lesions and (more anecdotally) for arthritis and gastro-intestinal manifestations. Two cases of neuro-Behcet treated with infliximab showed a complete resolution. Finally, in a rand…

medicine.medical_specialtyMucocutaneous zoneArthritisBehcet's diseaseDiseaseInterferon alpha-2Receptors Tumor Necrosis Factorlaw.inventionEtanerceptEtanerceptRheumatologyRandomized controlled triallawAntibodies Monoclonal; Behcet Syndrome; Chaperonin 60; Humans; Immunoglobulin G; Immunologic Factors; Interferon-alpha; Receptors Tumor Necrosis Factor; Recombinant ProteinsmedicineHumansImmunologic FactorsIFN-α2abusiness.industryBehcet SyndromeAntibodies MonoclonalInterferon-alphaChaperonin 60medicine.diseaseDermatologyeye diseasesInfliximabAdamantiades-Behçet's diseaseInfliximabRecombinant Proteinsstomatognathic diseasesImmunoglobulin GImmunologyTumour necrosis factorbusinessTolerizationUveitismedicine.drugCurrent opinion in rheumatology
researchProduct